PubMed Health⌕ Search

PubMed · 9132248

[Reoperation in laparoscopic procedures].

Abstract

Besides of really positives bring laparoscopic procedures also complications, which sometimes demand reoperation. When in our literature nobody mentioned this topics the authors bring their own experiences with reoperations after laparoscopic procedures. The authors in time from March 1992 to November 1995 performed together 1836 laparoscopic operations. 19 times, it means in 1.03%, the reoperations was needed. In the paper the authors discuss the causes of the reoperations, possibilities and methods of complications solution. They also discuss possibilities of complications prevention. The open surgery was performed in lesions of biliary tree, in pancreatitis, peritonitis and duodenal lesion. This type of surgery was performed also in hernia repair after technical error. Laparoscopic reoperations were performed in haemorrhage from the gallbladder bed, in pritonitis and in recurrent inquinal hernia. There is to be said, that laparoscopic reoperations need experience in this technique. In euphory from the growing laparoscopic surgery there is the need to remark also complications and unsuccesses. With gaining experiences it is possible to perform also reoperations laparoscopically. It is important to be sufficiently aggressive in diagnostic procedures and also in therapy of complications. It is advisable to use diagnostic laparoscopy with adequate solution of situations. Keeping this all in mind, there is possible to minimise the sequelae of complications and reoperations. There is also the possibility to prevent the reoperations.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Holéczy, J Malina. 1996. [Reoperation in laparoscopic procedures].. https://pubmed.ncbi.nlm.nih.gov/9132248/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗